Biomarin Pharmaceutical (BMRN) Tax Rate (2009 - 2026)

Biomarin Pharmaceutical has disclosed Tax Rate across 18 years of filings, most recently posting 25.27% for Q1 2026.

• Quarterly Tax Rate rose 326.0% year-over-year to 25.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 30.3% (up 800.0% YoY) and the FY2025 annual result came in at 27.69%, up 648.0% from the prior year.
• Tax Rate climbed to 25.27% in Q1 2026, from 71.52% in the prior quarter.
• Over five years, Tax Rate peaked at 98.58% in Q4 2022 and troughed at 249.37% in Q3 2022.
• A 5-year average of 1.81% and a median of 18.89% in 2024 frame the typical range for Tax Rate.
• Annual changes were most pronounced in 2022 — Tax Rate tumbled 27031 bps — and 2023, when it surged 25247 bps.
• Tracing BMRN's Tax Rate over 5 years: stood at 98.58% in 2022, then slumped by 106 bps to 5.42% in 2023, then jumped by 586 bps to 26.35% in 2024, then plunged by 371 bps to 71.52% in 2025, then surged by 135 bps to 25.27% in 2026.
• Business Quant data shows BMRN's Tax Rate at 25.27% in Q1 2026, 71.52% in Q4 2025, and 16.79% in Q3 2025.